235 related articles for article (PubMed ID: 11043658)
21. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391
[TBL] [Abstract][Full Text] [Related]
22. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
Burnley BT; George S
J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
Dolder PC; Liechti ME; Rentsch KM
Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.
Dolder PC; Schmid Y; Haschke M; Rentsch KM; Liechti ME
Int J Neuropsychopharmacol; 2015 Jun; 19(1):. PubMed ID: 26108222
[TBL] [Abstract][Full Text] [Related]
25. Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes.
Inoue T; Niwaguchi T; Murata T
Xenobiotica; 1980 Dec; 10(12):913-20. PubMed ID: 7210704
[TBL] [Abstract][Full Text] [Related]
26. LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor.
Favretto D; Frison G; Maietti S; Ferrara SD
Int J Legal Med; 2007 Jul; 121(4):259-65. PubMed ID: 16496170
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of lysergic acid diethylamide (LSD): an update.
Libânio Osório Marta RF
Drug Metab Rev; 2019 Aug; 51(3):378-387. PubMed ID: 31266388
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.
Reuschel SA; Eades D; Foltz RL
J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):145-59. PubMed ID: 10572980
[TBL] [Abstract][Full Text] [Related]
29. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry.
Bodin K; Svensson JO
Ther Drug Monit; 2001 Aug; 23(4):389-93. PubMed ID: 11477321
[TBL] [Abstract][Full Text] [Related]
30. LSD Detection and Interpretation in Hair.
Richeval C; Allorge D; Vanhoye X; Gaulier JM
Curr Pharm Des; 2017; 23(36):5496-5501. PubMed ID: 28641537
[TBL] [Abstract][Full Text] [Related]
31. Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography-Tandem Mass Spectrometry.
Patton AL; Brown J; Heine K; Sartori DA; Karschner EL; Walterscheid JP
J Anal Toxicol; 2023 May; 47(5):448-454. PubMed ID: 36801944
[TBL] [Abstract][Full Text] [Related]
32. Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
Johansen SS; Jensen JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):21-8. PubMed ID: 16154519
[TBL] [Abstract][Full Text] [Related]
33. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
34. Concentrations of LSD, 2-oxo-3-hydroxy-LSD, and iso-LSD in hair segments of 18 drug abusers.
Zheng J; Wang X; Zhang J; Ren H; Zhao Y; Xiang P
Forensic Sci Int; 2023 Mar; 344():111578. PubMed ID: 36753839
[TBL] [Abstract][Full Text] [Related]
35. Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry.
Canezin J; Cailleux A; Turcant A; Le Bouil A; Harry P; Allain P
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):15-27. PubMed ID: 11817305
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the lysergic acid diethylamide analog, 1-(thiophene-2-carbonyl)-N,N-diethyllysergamide (1T-LSD) from a blotter product.
Tanaka R; Kawamura M; Mizutani S; Kikura-Hanajiri R
Drug Test Anal; 2024 May; 16(5):482-488. PubMed ID: 37605503
[TBL] [Abstract][Full Text] [Related]
37. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
38. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
[TBL] [Abstract][Full Text] [Related]
39. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
40. Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes.
Bursztyka J; Perdu E; Tulliez J; Debrauwer L; Delous G; Canlet C; De Sousa G; Rahmani R; Benfenati E; Cravedi JP
Food Chem Toxicol; 2008 Mar; 46(3):939-48. PubMed ID: 18063284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
